Panacea Biotec Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec has informed the stock exchanges that its trading window will be closed for all designated persons and their immediate relatives from October 1, 2025, until 48 hours after the announcement of its unaudited financial results for the quarter and half year ending September 30, 2025. This closure is being done as per the company's insider trading code under SEBI regulations. The date of the board meeting to approve these Q2 and H1 FY26 results has not been announced yet and will be communicated later. This is a routine compliance filing and does not contain any financial numbers or business updates.
This is a standard regulatory filing with no direct impact on shareholders or the stock price. It simply means insiders cannot trade in the company's shares during the results announcement period, which is normal practice before quarterly results.